Transrectal Ultrasound | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0001 governing transrectal ultrasound coverage, with an effective date of March 7, 2026. Here's what billing teams need to do.

Aetna's transrectal ultrasound coverage policy under CPB 0001 has been updated. This policy governs transrectal ultrasound procedures — primarily used in prostate evaluation and biopsy guidance — and the modification may shift what Aetna considers medically necessary, covered, or experimental. The policy does not list specific CPT or HCPCS codes in the available data, which is itself a signal: review your current charge capture against Aetna's full published policy before billing for dates of service on or after March 7, 2026.

Quick-Reference Table

Aetna Transrectal Ultrasound Coverage Criteria and Medical Necessity Requirements 2026

CPB 0001 is Aetna's clinical policy bulletin governing transrectal ultrasound — a procedure most commonly associated with prostate cancer screening, prostate biopsy guidance, and evaluation of rectal or pelvic pathology. When Aetna modifies a coverage policy of this type, the changes typically fall into one of three buckets: tightened medical necessity criteria, reclassification of certain indications as experimental or investigational, or updated prior authorization requirements.

Because the detailed policy text wasn't captured in the version we received, billing teams shouldn't assume nothing significant changed. Aetna modifies CPB documents for substantive reasons — not housekeeping. A modification to a foundational policy like CPB 0001 Aetna warrants a direct review of the full published bulletin at Aetna's clinical policy portal.

What we do know is the structure of how Aetna typically handles transrectal ultrasound billing guidelines under this policy. Aetna generally requires that transrectal ultrasound meet specific medical necessity thresholds. For prostate-related indications, that typically means documented clinical findings — elevated PSA, abnormal digital rectal exam, prior biopsy history — before Aetna treats the procedure as covered rather than elective.

Prior authorization is a real risk in this space. Aetna's prior auth requirements for imaging procedures have tightened across the board since 2023, and transrectal ultrasound is not exempt. If your practice had an established workflow under the prior version of this policy, don't assume that workflow still holds after March 7, 2026. Verify with Aetna's auth portal or your provider rep before the next claim goes out.

The real issue here is that "modified" doesn't tell you the direction of the change. A modification could mean Aetna expanded coverage — adding new covered indications — or it could mean they narrowed it, moving indications to experimental status. Either way, your reimbursement exposure is real until you know which way this went.

Aetna Transrectal Ultrasound Exclusions and Non-Covered Indications

Without the full policy text, we can't list specific exclusions from the March 7, 2026 version. But the pattern with transrectal ultrasound policies across major payers is consistent enough to flag here.

Aetna has historically classified certain uses of transrectal ultrasound as experimental or investigational. Elastography-guided biopsy, contrast-enhanced transrectal ultrasound for prostate cancer characterization, and high-intensity focused ultrasound (HIFU) guidance have all appeared as non-covered or experimental indications in prior versions of Aetna's transrectal ultrasound coverage policy. If your practice uses advanced ultrasound modalities beyond standard grayscale transrectal imaging, those are your highest claim denial risk under this policy.

Any indication that lacked a strong evidence base before this modification is a candidate for reclassification. Pull the updated CPB 0001 text and check the "Experimental, Investigational, Unproven" section directly. That section is where Aetna defines what it won't pay for — and where most denials originate.

Coverage Indications at a Glance

Because the available policy data doesn't include the full indication-level detail from the March 7, 2026 version, the table below reflects Aetna's historically documented coverage positions for transrectal ultrasound under CPB 0001. Verify each row against the current published bulletin before using this as a billing reference.

Aetna Transrectal Ultrasound Billing Guidelines and Action Items 2026

This is where you stop reading and start doing. The effective date of March 7, 2026 is already in effect. If your practice bills transrectal ultrasound to Aetna commercial plans, act now.

CPT, HCPCS, and ICD-10 Codes for Transrectal Ultrasound Under CPB 0001

The policy data available for this modification does not include a specific code list. Aetna has not published the associated CPT, HCPCS, or ICD-10 codes in the version captured here.

This is not unusual for a CPB update — Aetna sometimes publishes policy changes before the full code appendix is updated. It does mean your billing team needs to go directly to the source.

How to Get the Actual Code List

Go to Aetna's clinical policy bulletin portal and pull CPB 0001 directly. The full bulletin includes a "Coding" section that lists the specific CPT and HCPCS codes Aetna applies this policy to. That section is the authoritative reference for your charge capture and prior auth setup.

The CPT codes most commonly associated with transrectal ultrasound procedures include those in the ultrasound and urological procedure families — but because the policy data above does not list specific codes, we are not publishing a code table here. Publishing assumed codes would create more risk for your billing team than publishing none at all.

Check the coding section of CPB 0001 for the specific codes Aetna recognizes under this policy, then cross-reference against your charge description master (CDM). If there are codes in your CDM that Aetna's published list doesn't include, that's a gap that will produce claim denials.